Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Triton Market Research report on the Latin American Alzheimer’s disease therapeutics and diagnostics market predicts the market to grow in terms of revenue with a CAGR of 8.70% during the forecast period between 2019 and 2027.

The countries that have been considered for analysis in the report on Latin America’s Alzheimer’s disease therapeutics and diagnostics market are:

•           Brazil

•           Mexico

•           Rest of Latin America         

The factors that primarily drive the Latin America Alzheimer’s disease therapeutics and diagnostics market are the rising mortality rates due to Alzheimer’s disease and the investments by made by the government for research in the field of AD and dementia. As per the Health Data Organization, Alzheimer’s disease was the third-most prevailing cause of deaths in Brazil in 2016. Moreover, investments made by national governments for research on these diseases also drive the Alzheimer’s disease therapeutics and diagnostics market in the region. In addition, the main aim of these investments is to enhance the quality of diagnostic procedures by promoting research in the field of Alzheimer’s and dementia which would lead to an increase in the awareness about Alzheimer’s diseases in Latin America. As a result, the demand for the Alzheimer’s disease therapeutic & diagnostic procedures is expected to rise, which would positively influence the growth of the market in this region.

In Brazil, more than a million people have been reported to be affected with some form of dementia. As the aging population witnesses an increase, age-related conditions such as dementia are also expected to be on the rise. Brazil has shown considerable progress in many aspects of public health, and its certain healthcare policies of providing high-cost medication free of charge have been a boon to people suffering from dementia. However, more needs to be done on this front as doctors need to be trained in the diagnosis of dementia, healthcare workers need to be trained in the long-term management of this condition and general awareness about dementia needs to be increased. The country needs to assess service provisions and how it \ will meet the needs of people suffering from this condition, considering issues such as population aging and health transitions in each country and ensuring that any measures taken to increase dementia diagnosis rates are coupled with adequate service provision. The rapid growth of the geriatric population in Brazil makes the country more vulnerable to the prevalence of dementia. The real prevalence of this disease needs to be determined for establishing appropriate measures to improve the quality of life of those affected with this condition.

Siemens Medical Solutions Inc. extensively develops, manufactures, and markets healthcare products across the world. With an employee strength of 377,000, it serves the markets of Latin America, Europe, North America, and Asia. Siemens has developed an imaging solution for the treatment of Alzheimer’s for the American healthcare market, through which the company plans to expand its business in the region. In April 2016, it received regulatory approval from the US FDA for its two new MRI applications – Simultaneous Multi-Slice (SMS) and GOBrain.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTIC MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCE MODEL

2.2.1. THREAT OF NEW ENTRANTS

2.2.2. THREATS OF SUBSTITUTE PRODUCT

2.2.3. BARGAINING POWER OF BUYER

2.2.4. BARGAINING POWER OF SUPPLIER

2.2.5. INTENSITY OF COMPETITIVE RIVALRY

2.3. VENDOR SCORECARD

2.4. ETYMOLOGY

2.5. PARENT MARKET OUTLOOK

2.6. STRATEGIC BUYING CRITERIA OUTLOOK

2.7. KEY FINDINGS

2.8. INDUSTRY STRUCTURE

2.8.1. RESEARCH AND DEVELOPMENT

2.8.2. MANUFACTURING

2.8.3. RAW MATERIALS

2.8.4. END USER

2.8.5. WHOLESALERS

2.9. ALZHEIMER'S DISEASE ETIOLOGY

2.10. PHASES AND STERNNESS OF ALZHEIMER’S DISEASE

2.11. MARKET DRIVERS

2.11.1. GROWTH OF THE ALZHEIMER’S DISEASE

2.11.2. GROWING GERIATRIC POPULATION

2.11.3. SUBSTANTIAL INVESTMENTS BY GOVERNMENT IN RESEARCH

2.12. MARKET RESTRAINTS

2.12.1. STRINGENT GOVERNMENT REGULATIONS

2.12.2. THE TREATMENT OF ALZHEIMER’S DISEASE COSTS VERY HIGH

2.13. MARKET OPPORTUNITIES

2.13.1. IN-VITRO DIAGNOSTIC TECHNIQUES ARE A BOON TO THE MARKET

2.13.2. R&D INVESTMENT IN THE PERSONALIZED MEDICINES IS INCREASING

2.14. MARKET CHALLENGES

2.14.1. AWARENESS IS LESS CONCERNING NEW THERAPIES IN THE ALZHEIMER’S DISEASE

2.14.2. VERY FEW SKILLED PROFESSIONALS PERTAINING TO THE TREATMENT OF ALZHEIMER’S DISEASE

3.    ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET OUTLOOK - BY THERAPEUTICS AND DIAGNOSTICS

3.1. THERAPEUTICS

3.1.1. THERAPEUTICS BY DRUGS

3.1.1.1. MARKETED DRUGS

3.1.1.2. PIPELINE DRUGS

3.1.2. THERAPEUTICS BY DISEASE STAGE

3.1.2.1. LATE STAGE: SEVERE AD

3.1.2.2. EARLY/MIDDLE STAGE: MILD TO MODERATE AD

3.1.3. PRODROMAL STAGE

3.1.4. THERAPEUTICS BY GENERIC AND BRANDED

3.1.4.1. BRANDED

3.1.4.2. GENERIC

3.2. DIAGNOSTIC TYPE

3.2.1. LUMBAR PUNCTURE TEST

3.2.2. POSITRON EMISSION TOMOGRAPHY

3.2.3. ELECTROENCEPHALOGRAPHY

3.2.4. MAGNETIC RESONANCE IMAGING

3.2.5. COMPUTED TOMOGRAPHY

3.2.6. OTHER DIAGNOSTICS

4.    ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET – LATIN AMERICA

4.1. MARKET BY THERAPEUTICS AND DIAGNOSTICS

4.2. COUNTRY ANALYSIS

4.2.1. BRAZIL

4.2.2. MEXICO

4.2.3. REST OF LATIN AMERICA

5.    COMPANY PROFILES

5.1. ABBVIE

5.2. AMARANTUS BIOSCIENCE HOLDINGS, INC.

5.3. AXON NEUROSCIENCE SE

5.4. BAXTER

5.5. BIOGEN

5.6. COGNOPTIX

5.7. DIAGENIC ASA

5.8. ROCHE

5.9. GE HEALTHCARE

5.10. MERCK

5.11. JOHNSON & JOHNSON

5.12. PIRAMAL ENTERPRISES LTD.

5.13. SIEMENS HEALTHINEERS AG

5.14. SUN PHARMACEUTICAL INDUSTRIES LTD.

6.    RESEARCH METHODOLOGY & SCOPE

6.1. RESEARCH SCOPE & DELIVERABLES

6.1.1. OBJECTIVES OF STUDY

6.1.2. SCOPE OF STUDY

6.2. SOURCES OF DATA

6.2.1. PRIMARY DATA SOURCES

6.2.2. SECONDARY DATA SOURCES

6.3. RESEARCH METHODOLOGY

6.3.1. EVALUATION OF PROPOSED MARKET

6.3.2. IDENTIFICATION OF DATA SOURCES

6.3.3. ASSESSMENT OF MARKET DETERMINANTS

6.3.4. DATA COLLECTION

6.3.5. DATA VALIDATION & ANALYSIS

List of table

TABLE 1        LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

TABLE 2        LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET IN THERAPEUTICS BY DRUGS 2019-2027 ($ MILLION)

TABLE 3        LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET IN DISEASE STAGE BY DRUGS 2019-2027 ($ MILLION)

TABLE 4        LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET IN THERAPEUTICS BY GENERIC AND BRANDED 2019-2027 ($ MILLION)

TABLE 5        LATIN AMERICA ALZHEIMER’S DISEASE DIAGNOSTICS MARKET BY DIAGNOSTIC TYPE 2019-2027 ($ MILLION)

TABLE 6        LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET BY THERAPEUTICS AND DIAGNOSTICS 2019-2027 ($ MILLION)

TABLE 7        LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)         

List of Figures

FIGURE 1      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 2      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET IN THERAPEUTICS 2019-2027 ($ MILLION)

FIGURE 3      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS MARKET IN MARKETED DRUGS 2019-2027 ($ MILLION)

FIGURE 4      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS MARKET IN PIPELINE DRUGS 2019-2027 ($ MILLION)

FIGURE 5      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS MARKET IN LATE STAGE: SEVERE AD 2019-2027 ($ MILLION)

FIGURE 6      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS MARKET IN EARLY/MIDDLE STAGE: MILD TO MODERATE AD 2019-2027 ($ MILLION)

FIGURE 7      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS MARKET IN PRODROMAL STAGE 2019-2027 ($ MILLION)

FIGURE 8      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS MARKET IN BRANDED 2019-2027 ($ MILLION)

FIGURE 9      LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS MARKET IN GENERIC 2019-2027 ($ MILLION)

FIGURE 10   LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTIC TYPE MARKET IN DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 11   LATIN AMERICA ALZHEIMER’S DISEASE DIAGNOSTICS MARKET IN LUMBAR PUNCTURE TEST 2019-2027 ($ MILLION)

FIGURE 12   LATIN AMERICA ALZHEIMER’S DISEASE DIAGNOSTICS MARKET IN POSITRON EMISSION TOMOGRAPHY 2019-2027 ($ MILLION)

FIGURE 13   LATIN AMERICA ALZHEIMER’S DISEASE DIAGNOSTICS MARKET IN ELECTROENCEPHALOGRAPHY 2019-2027 ($ MILLION)

FIGURE 14   LATIN AMERICA ALZHEIMER’S DISEASE DIAGNOSTICS MARKET IN MAGNETIC RESONANCE IMAGING 2019-2027 ($ MILLION)

FIGURE 15   LATIN AMERICA ALZHEIMER’S DISEASE DIAGNOSTICS MARKET IN COMPUTED TOMOGRAPHY 2019-2027 ($ MILLION)

FIGURE 16   LATIN AMERICA ALZHEIMER’S DISEASE DIAGNOSTICS MARKET IN OTHER DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 17   BRAZIL ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 18   MEXICO ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

FIGURE 19   REST OF LATIN AMERICA ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2019-2027 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;